- Home
- PMAX vs BGLC Comparison
PMAX vs BGLC Comparison
Compare PMAX & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMAX
- BGLC
- Stock Information
- Founded
- PMAX 2019
- BGLC 2017
- Country
- PMAX Hong Kong
- BGLC Malaysia
- Employees
- PMAX N/A
- BGLC N/A
- Industry
- PMAX
- BGLC Medical Specialities
- Sector
- PMAX
- BGLC Health Care
- Exchange
- PMAX Nasdaq
- BGLC Nasdaq
- Market Cap
- PMAX 4.7M
- BGLC 5.8M
- IPO Year
- PMAX 2024
- BGLC N/A
- Fundamental
- Price
- PMAX $0.39
- BGLC $2.88
- Analyst Decision
- PMAX
- BGLC
- Analyst Count
- PMAX 0
- BGLC 0
- Target Price
- PMAX N/A
- BGLC N/A
- AVG Volume (30 Days)
- PMAX 3.4M
- BGLC 1.8M
- Earning Date
- PMAX 05-06-2025
- BGLC 04-15-2025
- Dividend Yield
- PMAX N/A
- BGLC N/A
- EPS Growth
- PMAX N/A
- BGLC N/A
- EPS
- PMAX 0.04
- BGLC N/A
- Revenue
- PMAX $5,970,263.00
- BGLC $9,510,646.00
- Revenue This Year
- PMAX N/A
- BGLC N/A
- Revenue Next Year
- PMAX N/A
- BGLC N/A
- P/E Ratio
- PMAX $9.14
- BGLC N/A
- Revenue Growth
- PMAX 30.05
- BGLC N/A
- 52 Week Low
- PMAX $0.28
- BGLC $2.01
- 52 Week High
- PMAX $4.70
- BGLC $8.40
- Technical
- Relative Strength Index (RSI)
- PMAX N/A
- BGLC 51.78
- Support Level
- PMAX N/A
- BGLC $2.47
- Resistance Level
- PMAX N/A
- BGLC $2.99
- Average True Range (ATR)
- PMAX 0.00
- BGLC 0.49
- MACD
- PMAX 0.00
- BGLC 0.07
- Stochastic Oscillator
- PMAX 0.00
- BGLC 58.87
About PMAX Powell Max Limited Class A Ordinary Shares
Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. Key revenue is derived from Hong Kong.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.